Please login to the form below

Not currently logged in
Email:
Password:

Nanobiotix

This page shows the latest Nanobiotix news and features for those working in and with pharma, biotech and healthcare.

Positive data unlocks more EIB funding for Nanobiotix

Positive data unlocks more EIB funding for Nanobiotix

French biotech Nanobiotix has received a second 14m tranche from a European Investment Bank (EIB) loan, triggered by meeting two development objectives. ... Nanobiotix has previously received 16m from the EIB and can draw on the final 10m by July 2020.

Latest news

  • Nanobiotix signs €40m deal with the EIB Nanobiotix signs €40m deal with the EIB

    loan to fund innovative nanomedicine platform. France's nanomedicine specialist Nanobiotix has secured 40m from the European Investment Bank (EIB) to fund its research. ... Philippe Mauberna, chief financial officer of Nanobiotix, said: “This loan will

  • Lilly closes on first approval for sarcoma drug Lartruvo Lilly closes on first approval for sarcoma drug Lartruvo

    Meanwhile, Nanobiotix filed for approval of its radio-enhancer drug NBTXR3 for STS in Europe last week, while CytRx has an improved doxorubicin candidate called aldoxorubicin in late-stage testing.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Nanobiotix strengthens US leadership team Nanobiotix strengthens US leadership team

    Dr Obrocea (pictured right) joins Nanobiotix as head of US clinical development, bringing 20 years of clinical research leadership to the role. ... Meanwhile, Kurdi (pictured left) becomes director of investor relations at Nanobiotix, moving from the

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics